newsfilter
← Latest News
Business Wire·

FDA has declined Humanigen's Emergency Use Authorization (EUA) Request for Lenzilumab in Hospitalized COVID-19 Patients

FDA has committed to working with Humanigen in the development of lenzilumab and has invited Humanigen to submit additional data as it becomes available NIH's ACTIV-5/BET-B study is expected to provide further data that may support a new EUA reque